Versant Venture Capital VI, L.P. - Sep 18, 2025 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
10%+ Owner
Signature
Versant Vantage II, LP By: Versant Vantage II GP, L.P. Its: General Partner By: Versant Vantage II GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Stock symbol
LENZ
Transactions as of
Sep 18, 2025
Transactions value $
-$5,714,356
Form type
4
Date filed
9/22/2025, 04:23 PM
Previous filing
Sep 18, 2025
Next filing
Sep 23, 2025

Reporting Owners (9)

Name Relationship Address Signature Signature date CIK
Versant Venture Capital VI, L.P. 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Vantage II, LP By: Versant Vantage II GP, L.P. Its: General Partner By: Versant Vantage II GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001687880
Versant Ventures VI GP, L.P. 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Vantage II GP, L.P., By: Versant Vantage II GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001777654
Versant Ventures VI GP-GP, LLC 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Vantage II GP-GP, LLC, By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001777652
Versant Vantage II, L.P. 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001832235
Versant Vantage II GP, L.P. 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Ventures VI GP, L.P., By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001839790
Versant Vantage II GP-GP, LLC 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Ventures VI GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001839789
Versant Venture Capital VII, L.P. 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001750266
Versant Ventures VII GP, L.P. 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Ventures VII GP, L.P., By: Versant Ventures VII GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001777655
Versant Ventures VII GP-GP, LLC 10%+ Owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer 2025-09-22 0001777656

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LENZ Common Stock Sale -$2.06M -49.5K -3.88% $41.59 1.22M Sep 18, 2025 Direct F1, F2
transaction LENZ Common Stock Sale -$1.01M -24.4K -2.71% $41.59 876K Sep 18, 2025 See Footnote F1, F3
transaction LENZ Common Stock Sale -$1.76M -40.9K -3.34% $43.00 1.18M Sep 18, 2025 Direct F2, F4
transaction LENZ Common Stock Sale -$866K -20.1K -2.3% $43.00 856K Sep 18, 2025 See Footnote F3, F4
transaction LENZ Common Stock Sale -$11.6K -268 -0.02% $43.30 1.18M Sep 18, 2025 Direct F2
transaction LENZ Common Stock Sale -$5.72K -132 -0.02% $43.30 856K Sep 18, 2025 See Footnote F3
holding LENZ Common Stock 842K Sep 18, 2025 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $41.25 to $42.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
F2 These shares are held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Each of VV VI GP and VV VI may be deemed to share voting, investment and dispositive power over the shares held by VVC VI and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
F3 These shares are held by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP-GP, LLC ("VV VII GP") is the sole general partner of Versant Ventures VII GP, L.P. ("VV VII") and VV VII is the sole general partner of VVC VII. Each of VV VII GP and VV VII may be deemed to share voting, investment and dispositive power over the shares held by VVC VII and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.
F4 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.25 to $43.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
F5 These shares are held by Versant Vantage II, L.P. ("VV II"). Versant Vantage II GP-GP, LLC ("VV II GP-GP") is the sole general partner of Versant Vantage II GP, L.P. ("VV II GP") and VV II GP is the sole general partner of VV II. Each of VV II GP-GP and VV II GP may be deemed to share voting, investment and dispositive power over the shares held by VV II and disclaims beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein.